ACM
Aecom
ACM has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over ACM overall, supported by stronger modeled upside and stronger fundamentals.
ACM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Stable |
ACM's revenue, profitability and balance sheet are currently stable, but its cash flow is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ACM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $70.11 | — |
| Cheap | 25x | $54.07 | -23% |
| Current | 32x | $70.11 | — |
| Fair | 36x | $77.53 | +11% |
| Expensive | 63x | $138 | +96% |
Historical ranges are pointers, not guarantees.
ACM's PE is in its fair range at 32x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ACM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect ACM's earnings to grow, with its revenue and profitability holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over ACM on the outlook, with more favorable revenue and profitability expectations.
ACM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.23 | +186% |
| Q2 2026 | $2.18 | -52% |
| Q1 2026 | $3.83 | -16% |
| Q4 2025 | $3.52 | +0.3% |
| Q3 2025 | $4.21 | +43% |
| Q2 2025 | $4.58 | +146% |
| Q1 2025 | $4.58 | +$4.67 |
| Q4 2024 | $3.51 | +680% |
| Q3 2024 | $2.95 | +656% |
ACM has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ACM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.6B | -14% |
| Q1 2026 | $3.8B | +0.8% |
| Q4 2025 | $3.8B | -4.6% |
| Q3 2025 | $4.2B | +1.6% |
| Q2 2025 | $4.2B | +0.7% |
| Q1 2025 | $3.8B | -4.4% |
| Q4 2024 | $4B | +2.9% |
| Q3 2024 | $4.1B | +7% |
ACM's revenue has slid since its 2019 peak: $3.6B last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | -9.2 points |
| Q1 2026 | 6.5% | -0.3 points |
| Q4 2025 | 5.8% | -0.1 points |
| Q3 2025 | 5.7% | -0.1 points |
| Q2 2025 | 7% | +1.6 points |
| Q1 2025 | 6.8% | +1.8 points |
| Q4 2024 | 5.9% | +1.7 points |
| Q3 2024 | 5.8% | +3.7 points |
ACM has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ACM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ACM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $54.9M | -79% |
| Q1 2026 | -$27.4M | -115% |
| Q4 2025 | $41.9M | -62% |
| Q3 2025 | $134.1M | -51% |
| Q2 2025 | $261.7M | -4.1% |
| Q1 2025 | $178.3M | +141% |
| Q4 2024 | $110.9M | +28% |
| Q3 2024 | $274.5M | +4.4% |
ACM has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ACM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -671K shares |
| 1 year | -3.4% | -4.5M shares |
| 3 years | -7.3% | -10.2M shares |
| 5 years | -14% | -20.3M shares |
| Available history | -18% | -29.1M shares |
ACM has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $6,000 |
| Q1 2026 | $116M |
| Q4 2025 | $325.9M |
| Q3 2025 | $250.1M |
| Q2 2025 | $4.7M |
| Q1 2025 | $78.5M |
| Q4 2024 | $55.2M |
| Q3 2024 | $315.4M |
ACM spent $692M buying back its own shares over the past year, up 53% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ACM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.0x | Moderate |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.9x | Very low |
| Q3 2024 | 0.9x | Very low |
ACM's net debt is about 2.0 years of its operating earnings (EBITDA), up from less than a year a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.1 | Neutral |
| Stochastic | 50.5 | Neutral |
ACM's weekly RSI is 51 (neutral) and its Stochastic is 51 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ACM PE vs Industrials Sector
| Metric | ACM | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 24x | 34% above |
| PE % | 40 | 58 | 18 pts below |
ACM is trading at 32x earnings, a 34% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ACM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 12% above |
| 20 week MA | $65.6 | 6.9% above |
| 50 week MA | $78.7 | 11% below |
| 100 week MA | $95.2 | 26% below |
| 200 week MA | $92.8 | 24% below |
ACM has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 24% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over ACM on trend strength, trading above more of its moving averages.
ACM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.2 | $48.7 | +13% |
| 2021 | $48.7 | $75.9 | +56% |
| 2022 | $75.9 | $84.7 | +12% |
| 2023 | $84.7 | $92.4 | +9.1% |
| 2024 | $92.4 | $107.7 | +16% |
| 2025 | $107.7 | $97.4 | -9.5% |
| 2026 YTD | $97.4 | $70.1 | -28% |
ACM has finished higher in five of the last six years. It's down 28% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over ACM on returns for 2026, with the stronger performance.